Skip to main content

Truvada Sales Data

Rank 22 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Truvada U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 22 0.03% -0.56%
Q3 2013 22 (2) -1.67% -4.12%
Q2 2013 20 (1) 2.78% 1.82%
Q1 2013 21 (2) -5.11% -8.51%
Q4 2012 19 (1) 2.64% 3.81%
Q3 2012 18 (5) 1.56% 0.52%
Q2 2012 23 -0.60% -0.52%
Q1 2012 23 (2) 8.31% 2.85%
Q4 2011 25 3.43% 3.31%
Q3 2011 25 (2) 1.15% 1.69%
Q2 2011 27 (1) 8.66% 1.71%
Q1 2011 28 n/a n/a

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
October 7, 2021Awareness of, Referral to HIV PrEP Low Among Hispanics
August 26, 2021Some High-Priority Groups More Likely to Stop Taking PrEP
August 12, 2021Bimonthly, Injected PrEP Beats Daily Pill in Warding Off HIV: Study
August 5, 2021Health Highlights: Aug. 5, 2021
July 21, 2021PrEP HIV Prevention Pills to Be Free for Insured Americans
July 21, 2021Health Highlights: July 21, 2021
July 2, 2021HIV Incidence Remains Low With PrEP in Real-World Setting